(2,4,6-trioxo-1,3,5-triazine-1,3,5(2H,4H,6H)-triyl)tri-2,1-ethanediyl triacrylate

Genetic toxicity: in vivo

Administrative data

Endpoint:

in vivo mammalian cell study: DNA damage and/or repair

Type of information:

experimental study planned

Justification for type of information:

CONSIDERATIONS OF ALTERNATIVE METHODS ON TESTING PROPOSALS IN YOUR REGISTRATION

Public substance name: Tris(2-hydroxyethyl) isocyanurate triacrylate
EC Number: 254-843-6
CAS Number: 40220-08-4

Date of considerations: 21 December 2018

Hazard endpoint for which vertebrate testing was proposed:
In vivo mammalian alkaline comet assay (test method: OECD TG 489)

Considerations that the general adaptation possibilities of Annex XI of the REACH Regulation were not adequate to generate the necessary information

• available GLP studies
None.

• available non-GLP studies
None.

• historical human data
None.

• (Q)SAR
No reliable QSAR model is available to replace the in vivo Comet assay in rodents.

• in vitro methods
In vitro study (Ames test) has already performed on Tris(2-hydroxyethyl) isocyanurate triacrylate. As the results is positive, an in vivo study is required to evaluate the relevance of the in vitro positive results.

• weight of evidence
No data is available which allow a weight of evidence approach.

• grouping and read-across
None

• substance-tailored exposure driven testing [if applicable]
Not applicable

• [approaches in addition to above [if applicable]
Not applicable

• other reasons [if applicable]
None


Considerations that the specific adaptation possibilities of Annexes VI to X (and column 2 thereof) were not applicable:

Test proposal is fully compliant with ECHA guidance R 7.a (2017, page 575).
No specific adaptation possibilities of Annexes VI to X (and column 2 thereof) are applicable.

According to the OECD guidance R7A, when an Ames test was positive, an in vivo study could be proposed instead of launching both in vitro tests on mammalian cells. Indeed, with one positive in vitro test, an in vivo study is required in the REACH regulation. The in vivo alkaline comet assay (OECD 489) recognises primary DNA damage that would lead to gene mutations and/or chromosome aberrations, but will also detect DNA damage that may be effectively repaired or lead to cell death. The comet assay can be applied to almost every tissue of an animal from which single cell or nuclei suspensions can be made, including specific site of contact tissues.

Materials and methods

Test guideline

Qualifier:

according to guideline

Guideline:

OECD Guideline 489 (In vivo Mammalian Alkaline Comet Assay)

Test material

Test material information

1

Reference substance name:

(2,4,6-trioxo-1,3,5-triazine-1,3,5(2H,4H,6H)-triyl)tri-2,1-ethanediyl triacrylate

EC Number:

254-843-6

EC Name:

(2,4,6-trioxo-1,3,5-triazine-1,3,5(2H,4H,6H)-triyl)tri-2,1-ethanediyl triacrylate

Cas Number:

40220-08-4

Molecular formula:

C18H21N3O9

IUPAC Name:

(2,4,6-trioxo-1,3,5-triazinane-1,3,5-triyl)triethane-2,1-diyl trisacrylate